New Medicines: Better Outcomes?

20-Jan-2016

21 April 2016, ABPI Annual Conference and Dinner, London, UK

21 April 2016

ABPI Annual Conference and Dinner

London, UK


This year the ABPI's annual conference will discuss three core themes:

  • In the world of global medicines development, how does the UK become a world-leader in the new medicines that are on the horizon?
  • From a policy perspective, can we transform the way patients interact with medicines across the development and treatment pathways?
  • How can industry work in partnership with the NHS to make the new medicines opportunity real and drive better health for patients?

Organiser: Association of the British Pharmaceutical Industry (ABPI)

Companies

Featured Companies

Related Content

ABPI urges the UK to address the skills shortage in STEM
ABPI urges the UK to address the skills shortage in STEM
Scotland’s manufacturing exports worth £462 million
Scotland’s manufacturing exports worth £462 million
From molecule to medicine
From molecule to medicine
Embracing new innovation in the face of Brexit
Embracing new innovation in the face of Brexit
UK steps up its role in fighting global AMR
UK steps up its role in fighting global AMR
At the frontier of brain tumour research, leave no stone unturned
At the frontier of brain tumour research, leave no stone unturned
New Lung Health Taskforce to tackle Britain’s third biggest killer
New Lung Health Taskforce to tackle Britain’s third biggest killer
Life sciences leaders welcome Brexit position paper on future of UK science
Life sciences leaders welcome Brexit position paper on future of UK science
ABPI calls on UK government to address poor investment performance
ABPI calls on UK government to address poor investment performance
ABPI responds to NICE/NHS England consultation on evaluating and funding new medicines
ABPI responds to NICE/NHS England consultation on evaluating and funding new medicines
UK drug discovery landscape in fundamental shift towards collaboration and open innovation
UK drug discovery landscape in fundamental shift towards collaboration and open innovation
Pharmaceutical industry invests £340.3m to improve patient care, reports APBI
Pharmaceutical industry invests £340.3m to improve patient care, reports APBI
Further reaction to the EU referendum result
Further reaction to the EU referendum result
New report on cancer care across Europe reveals UK to be below average on cancer spend, survival rates and patient access to new medicines
New report on cancer care across Europe reveals UK to be below average on cancer spend, survival rates and patient access to new medicines
Attracting pharma manufacturing to the UK
Attracting pharma manufacturing to the UK